Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

epirubicin hydrochloride, Quantity: 2 mg/mL

Disponível em:

Hospira Australia Pty Ltd

DCI (Denominação Comum Internacional):

epirubicin hydrochloride

Forma farmacêutica:

Injection

Composição:

Excipient Ingredients: sodium chloride; water for injections; hydrochloric acid

Via de administração:

Intravenous, Intravesical

Unidades em pacote:

1 x 10 mL pack

Classe:

Medicine Listed (Export Only)

Tipo de prescrição:

Not scheduled. Not considered by committee

Indicações terapêuticas:

Epirubicin Hydrochloride is used in the treatment of: - Breast, ovarian, stomach, lung and colorectal cancer - Malignant lymphoma e.g. Hodgkin's disease and non-Hodgkin's lymphoma - Multiple myeloma - Non-invasive bladder cancer Epirubicin is also used to help prevent recurrence of bladder cancer after surgery.

Resumo do produto:

Visual Identification: A clear red solution free from visible particulates; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status de autorização:

Listed (Export Only)

Data de autorização:

2007-10-17